Update: Government to delay controversial NHS data sharing plan

'This process is a mess', say campaign groups

The UK AI health company touted by Matt Hancock was delisted by the New York Stock Exchange last month and has now called in the administrators

Critics complain 12-month deal lacks transparency, skips over provision for patient consent, and excludes other potential bidders